Publication date: Dec 01, 2025
Antibody repurposing is the process of changing a known antibody so that it binds to a mutated antigen. One of the findings to emerge from the Coronavirus Disease 2019 (COVID-19) pandemic was that it was possible to repurpose neutralizing antibodies for Severe Acute Respiratory Syndrome, a related disease, to work for COVID-19. Thus, antibody repurposing is a possible pathway to prepare for and respond to future pandemics, as well as personalizing cancer therapies. For antibodies to be successfully repurposed, it is necessary to know both how antigen mutations disrupt their binding and how they should be mutated to recover binding, with this work describing an analysis to address the first of these topics. Every possible antigen point mutation in the interface of 246 antibody-protein complexes were analyzed using the Rosetta molecular mechanics force field. The results highlight a number of features of how antigen mutations affect antibody binding, including the effects of mutating critical hotspot residues versus other positions, how many mutations are necessary to be likely to disrupt binding, the prevalence of indirect effects of mutations on binding, and the relative importance of changing attractive versus repulsive energies. These data are expected to be useful in guiding future antibody repurposing experiments.
Concepts | Keywords |
---|---|
Antibodies | Antibody repurposing |
Coronavirus | antigen mutations |
Covid | computational analysis |
Future | hotspot residues |
Pandemic | point mutations |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | process |
disease | MESH | Coronavirus Disease 2019 |
disease | MESH | Severe Acute Respiratory Syndrome |
disease | MESH | cancer |
disease | MESH | point mutation |
disease | IDO | protein |